Barclays PLC Regeneron Pharmaceuticals, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

A detailed history of Barclays PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Barclays PLC holds 3,600 shares of REGN stock, worth $2.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,600
Previous 3,600 -0.0%
Holding current value
$2.57 Million
Previous $3.79 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$1024.09 - $1201.76 $64.1 Million - $75.3 Million
62,632 Added 17.89%
412,747 $434 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $5.74 Million - $6.96 Million
6,497 Added 1.89%
350,115 $368 Million
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $41 Million - $45.1 Million
45,381 Added 15.22%
343,618 $331 Million
Q4 2023

Feb 15, 2024
BUY
$775.18 - $881.7 $33.6 Million - $38.2 Million
43,367 Added 17.02%
298,237 $262 Million
Q3 2023

Nov 07, 2023
SELL
$692.45 - $844.37 $16.7 Million - $20.4 Million
-24,114 Reduced 8.64%
254,870 $210 Million
Q2 2023

Aug 03, 2023
BUY
$700.03 - $830.35 $71.9 Million - $85.3 Million
102,689 Added 58.25%
278,984 $200 Million
Q1 2023

May 04, 2023
SELL
$680.49 - $826.97 $35.3 Million - $42.9 Million
-51,879 Reduced 22.74%
176,295 $145 Million
Q4 2022

Feb 13, 2023
BUY
$705.89 - $766.39 $51.1 Million - $55.4 Million
72,348 Added 46.43%
228,174 $165 Million
Q3 2022

Nov 03, 2022
BUY
$573.97 - $724.32 $20.4 Million - $25.8 Million
35,584 Added 29.59%
155,826 $107 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $22.2 Million - $30 Million
-40,548 Reduced 25.22%
120,242 $71.1 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $196 Million - $230 Million
-328,819 Reduced 67.16%
160,790 $112 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $93.7 Million - $116 Million
172,347 Added 54.32%
489,609 $309 Million
Q3 2021

Nov 09, 2021
BUY
$574.03 - $680.96 $80.1 Million - $95 Million
139,464 Added 78.44%
317,262 $192 Million
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $9.25 Million - $10.9 Million
19,565 Added 12.36%
177,798 $99.3 Million
Q1 2021

May 13, 2021
SELL
$446.73 - $548.2 $6.68 Million - $8.2 Million
-14,949 Reduced 8.63%
158,233 $74.9 Million
Q4 2020

Feb 11, 2021
BUY
$478.3 - $607.98 $14.1 Million - $17.9 Million
29,514 Added 20.54%
173,182 $83.7 Million
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $12.6 Million - $15.3 Million
-23,180 Reduced 13.89%
143,668 $80.4 Million
Q2 2020

Aug 12, 2020
BUY
$493.32 - $643.92 $788,325 - $1.03 Million
1,598 Added 0.97%
166,848 $104 Million
Q1 2020

May 13, 2020
SELL
$336.18 - $494.43 $25.9 Million - $38.1 Million
-77,090 Reduced 31.81%
165,250 $80.7 Million
Q4 2019

Feb 10, 2020
SELL
$274.13 - $376.51 $6.54 Million - $8.98 Million
-23,854 Reduced 8.96%
242,340 $91 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $20.4 Million - $23.8 Million
74,612 Added 38.95%
266,194 $73.8 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $20.8 Million - $28.7 Million
69,291 Added 56.66%
191,582 $60 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $983,035 - $1.16 Million
2,642 Added 2.21%
122,291 $50.2 Million
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $13.4 Million - $16.1 Million
-39,872 Reduced 24.99%
119,649 $44.7 Million
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $9.29 Million - $10.8 Million
26,444 Added 19.87%
159,521 $64.5 Million
Q2 2018

Aug 14, 2018
SELL
$284.6 - $344.99 $19.8 Million - $24 Million
-69,608 Reduced 34.34%
133,077 $45.9 Million
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $13.5 Million - $16.8 Million
42,672 Added 26.67%
202,685 $69.8 Million
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $11.4 Million - $15 Million
-31,834 Reduced 16.59%
160,013 $60.2 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $82.8 Million - $96.7 Million
191,847
191,847 $85.8 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email